MNG70
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 18 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| PROTEIN_SECRETION | 0.295 | Remibrutinib | — uncovered |
| MYC_TARGETS_V1 | 0.289 | Inavolisib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.230 | Inavolisib | — uncovered |
| DNA_REPAIR | 0.223 | Idelalisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.202 | Idelalisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.182 | Remibrutinib | — uncovered |
| PEROXISOME | 0.176 | Idelalisib | — uncovered |
| HEME_METABOLISM | 0.157 | Temsirolimus | — uncovered |
| UV_RESPONSE_DN | 0.138 | Inavolisib | — uncovered |
| TGF_BETA_SIGNALING | 0.134 | Inavolisib | — uncovered |
| ADIPOGENESIS | 0.123 | Inavolisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.121 | Inavolisib | — uncovered |
| MYOGENESIS | 0.092 | Inavolisib | — uncovered |
| INTERFERON_ALPHA_RESPONSE | 0.089 | Inavolisib | — uncovered |
| MITOTIC_SPINDLE | 0.087 | Inavolisib | — uncovered |
| E2F_TARGETS | 0.064 | Inavolisib | — uncovered |
| FATTY_ACID_METABOLISM | 0.057 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.012 | Idelalisib | — uncovered |